Journal of Clinical Pharmacy and Therapeutics 2003-02-01

Reassessing the contraindication of zolmitriptan and serotonin reuptake inhibitors: an evidence-based pharmacotherapeutic case report.

A S W Boutilier, D M Gardner

Index: J. Clin. Pharm. Ther. 28(1) , 69-72, (2003)

Full Text: HTML

Abstract

Related Compounds

  • Zolmitriptan

Related Articles:

Bioenhanced sublingual tablet of drug with limited permeability using novel surfactant binder and microencapsulated polysorbate: In vitro/in vivo evaluation.

2015-08-01

[Eur. J. Pharm. Biopharm. 94 , 386-92, (2015)]

Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.

2013-01-01

[PLoS ONE 8(1) , e52683, (2013)]

Preparation and evaluation of zolmitriptan submicron emulsion for rapid and effective nasal absorption in beagle dogs.

2011-12-01

[Drug Dev. Ind. Pharm. 37(12) , 1509-16, (2011)]

Evaluation of submicron emulsion as vehicles for rapid-onset intranasal delivery and improvement in brain targeting of zolmitriptan.

2011-11-01

[Drug Deliv. 18(8) , 578-85, (2011)]

Quantitative determination of zolmitriptan in rat blood and cerebrospinal fluid by reversed phase HPLC-ESI-MS/MS analysis: application to in vivo preclinical pharmacokinetic study.

2012-07-15

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 901 , 72-8, (2012)]

More Articles...